Growth Metrics

OptimizeRx (OPRX) Profit After Tax (2016 - 2026)

OptimizeRx's Profit After Tax history spans 16 years, with the latest figure at $5.0 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 6535.9% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 million, a 125.52% increase, with the full-year FY2025 number at $5.1 million, up 125.52% from a year prior.
  • Profit After Tax hit $5.0 million in Q4 2025 for OptimizeRx, up from $779000.0 in the prior quarter.
  • Over the last five years, Profit After Tax for OPRX hit a ceiling of $5.0 million in Q4 2025 and a floor of -$9.1 million in Q3 2024.
  • Historically, Profit After Tax has averaged -$2.2 million across 5 years, with a median of -$2.5 million in 2023.
  • Biggest five-year swings in Profit After Tax: plummeted 8790.01% in 2022 and later skyrocketed 6535.9% in 2025.
  • Tracing OPRX's Profit After Tax over 5 years: stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then plummeted by 1171.19% to -$4.1 million in 2023, then surged by 98.12% to -$78000.0 in 2024, then skyrocketed by 6535.9% to $5.0 million in 2025.
  • Business Quant data shows Profit After Tax for OPRX at $5.0 million in Q4 2025, $779000.0 in Q3 2025, and $1.5 million in Q2 2025.